Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Screening

Biology dictates the fate of young women with breast cancer

Nature Reviews Clinical Oncology volume 10, pages 673–675 (2013)Cite this article

Subjects

Controversy surrounds the use of mammography for breast cancer screening. This commentary explains why retrospective analyses of women who die from breast cancer do not add to the body of knowledge about the value of screening in young women. Mammographic screening alone cannot be expected to overcome aggressive biology.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Webb, M. L. et al. A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened. Cancer http://dx.doi.org/10.1002/cncr.28199.

  2. Slamon, D. J. et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177–182 (1987).

    Article  CAS  Google Scholar 

  3. Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 98, 10869–10874 (2001).

    Article  CAS  Google Scholar 

  4. van't Veer, L. J. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530–536 (2002).

    Article  CAS  Google Scholar 

  5. Michaelson, J. et al. The pattern of breast cancer screening utilization and its consequences. Cancer 94, 37–43 (2002).

    Article  Google Scholar 

  6. Lin, C. et al. Locally advanced breast cancers are more likely to present as interval cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial). Breast Cancer Res. Treat. 132, 871–879 (2012).

    Article  Google Scholar 

  7. Esserman, L. J., Thompson, I. M. Jr & Reid, B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA 310, 797–798 (2013).

    Article  CAS  Google Scholar 

  8. Barker, A. D. et al. I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clin. Pharmacol. Ther. 86, 97–100 (2009).

    Article  CAS  Google Scholar 

  9. Esserman, L. J. et al. Impact of mammographic screening on the detection of good and poor prognosis breast cancers. Breast Cancer Res. Treat. 130, 725–734 (2011).

    Article  Google Scholar 

  10. Michailidou, K. et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet. 45, 353–361 (2013).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

M. Eklund is funded by the Swedish Council for Working Life and Social Research (FAS), project number 2012-0073.

Author information

Authors and Affiliations

  1. Department of Surgery, UCSF Comprehensive Cancer Center, 1600 Divisadero Street, 2nd Floor, Box 1710, San Francisco, 94115, CA, USA

    Martin Eklund & Laura J. Esserman

Authors
  1. Martin Eklund
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura J. Esserman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laura J. Esserman.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eklund, M., Esserman, L. Biology dictates the fate of young women with breast cancer. Nat Rev Clin Oncol 10, 673–675 (2013). https://doi.org/10.1038/nrclinonc.2013.196

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrclinonc.2013.196

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer